Patient acquisition cost (CAC) is what a dental clinic spends to bring in one new patient, and the formula is simple: acquisition costs for a period divided by the new patients acquired in that period. The real work is deciding what counts as a cost, what counts as an acquired patient and whether that patient generates enough contribution, on time, to justify the spend.
A clinic can celebrate a flood of new leads and still destroy its margin. It can also lower its cost per lead and get worse results, because it attracts people who aren't a good fit, overloads the front desk, increases no-shows and fills appointment slots that could have gone to treatment already recommended.
The problem isn't advertising. It's measuring acquisition only halfway. A lead isn't a new patient, a booked consultation isn't a completed visit, an accepted treatment plan isn't a payment and revenue isn't contribution. When those steps get mixed up, managers raise the budget based on a conversion that hasn't turned into cash or well-used chair time.
Management view: there's no such thing as a good patient acquisition cost in absolute terms. There's only a CAC that is compatible, or not, with the contribution it generates, the time until payment, the capacity available and the quality of the relationship.
The mistake starts with how you define an acquired patient
The usual definition of CAC is the investment in a strategy divided by the number of new customers it generated. The formula is useful, but "new customer" needs a working definition before you run the numbers. Otherwise, two people can look at the same campaign and come up with two different results.
In a dental clinic, the funnel usually has at least five distinct events:
- an identified contact, with its source recorded
- a scheduled new patient exam
- a completed new patient exam
- a clinically recommended treatment that the patient accepts
- the first confirmed payment from a new patient
For investment decisions, the most conservative definition is usually the last one. It keeps the clinic from calling a no-show or an unpaid treatment plan an "acquisition." If the first visit is paid, the clinic can use that first payment as the acquisition event and track treatment start as a later conversion. The point isn't to impose a universal definition. It's to choose one rule, document it and keep it stable.
Consistency rule: the denominator of your CAC should be an event that both billing and operations can confirm, not an expectation recorded only by the ad platform.
How to calculate your clinic's real patient acquisition cost
The basic math is simple:
CAC = acquisition costs for the period ÷ new patients acquired in the period
The hard part is deciding which costs go in. If the clinic includes paid media but leaves out the agency, content production, software, commissions and the hours spent handling new patient inquiries, it's calculating a media CAC, not a business CAC. Both can be useful, as long as they have different names.
Use two layers of cost
| Layer | What goes in | Decision it supports |
|---|---|---|
| Media CAC | Direct ad spend divided by attributed new patients | Comparing campaigns within the same channel, using the same attribution rule |
| Full CAC | Media, partners, content, tools and measurable sales effort | Deciding budget, channels, staffing and the pace of growth |
Attribution changes the result, too
Google Ads explains that the last-click model gives all the credit to the final interaction and ignores earlier touchpoints in the journey. For many conversion actions, the platform uses data-driven attribution by default, based on the account's own history.
In practice: if a patient heard about the clinic from a friend, checked your Google profile, clicked an ad and then sent a text, the last click doesn't prove the ad created that demand on its own. That's why the clinic should record the source the patient reports, the technical source available and the attribution rule used. When sources disagree, that's something to investigate, not a reason to pick the most flattering number.
Patient lifetime value should measure contribution, not exploitation
Harvard Business School describes customer lifetime value as a metric that connects three strategies: acquisition, maximizing value and retention over the course of the relationship. In healthcare, that logic needs a clear limit. The relationship doesn't exist to manufacture demand. Treatment and recall visits depend on clinical need, informed consent and appropriate continuity of care.
So instead of asking "how much is a patient worth?", ask "what economic contribution does a cohort of new patients generate, within the care that was actually recommended, and how much of it remains after variable costs?" That question is more precise and lowers the risk of confusing gross revenue with economic value.
Start with a window you can observe
If the clinic doesn't have reliable history yet, projecting a "lifetime value" creates false precision. It's more prudent to track contribution at 90 days and at 12 months for each intake cohort. Contribution should start from payments actually received and subtract the variable costs directly tied to them, classified with your accountant. Associate pay, lab fees, supplies and card fees can vary by contract, specialty and how the clinic is set up.
12-month contribution = payments from the cohort − attributable variable costs
You can compare that number with the full CAC for the same cohort. Don't use a universal ratio as an automatic rule. A clinic with long treatment cycles, payment plans, strong referrals or limited capacity will behave differently from one that offers shorter services. The right limit is the one that protects cash flow, margin, quality and capacity within the clinic's real strategy.
Continuity is a quality indicator, not just a retention metric
The OECD's 2025 PaRIS survey of people living with chronic conditions links a longer relationship with the same primary care provider to better reported quality of care. It isn't a dental benchmark and shouldn't be turned into a target, but it reinforces that long-term relationships in healthcare are tied to trust and an accumulated understanding of the patient.
Another OECD analysis found that patients who had to repeat information that should already have been in their records gave positive ratings for trust and quality of care about 15 percentage points less often, on average. For a clinic, the takeaway is direct: healthy retention depends on continuity of information, not on one-off promotional blasts.
Practical decision: track recommended and completed recall visits, treatment plan continuity, cancellations and reasons for loss. But never treat the absence of a new procedure as a sales failure when there's no clinical need.
The investment memo every manager should ask for
Before you increase, keep or cut a channel, put together a one-page decision memo. It needs five blocks and should fit into one focused conversation with marketing, the front desk, billing and clinical leadership.
| Block | Question | Minimum evidence |
|---|---|---|
| Hypothesis | Why should this channel bring the right kind of demand? | Defined audience, service, area, capacity and goal |
| Funnel | Where does the cohort move forward or drop off? | Contact, scheduling, show rate, acceptance, treatment start and first payment |
| Economics | Does the contribution cover acquisition and operations? | Full CAC, contribution at 90 days and 12 months, time to payment |
| Balance | Did growth make another part of the clinic worse? | Wait times, no-shows, overtime, cancellations, complaints and rework |
| Decision | What changes, who does it and when do we review it? | Keep, test, scale back or pause, with an owner and a date |
Three readings that prevent rushed decisions
CAC went up and conversion went down
Don't conclude that the ads got worse until you've checked response time, schedule availability, the profile of incoming contacts, no-shows and the quality of source tracking.
CAC went down and contribution went down too
Cheap acquisition may be bringing in demand that isn't a good fit, or pushing lower-contribution services into capacity that's already scarce.
CAC and contribution improved, but wait times grew
The campaign worked, but operations hit their limit. The right call may be to slow down acquisition, rebalance the schedule or fix the bottleneck before buying more demand.
The minimum cohort dashboard
A cohort groups patients acquired in the same period through the same channel. Comparing cohorts keeps you from mixing old campaigns, fee changes and seasonal effects. The dashboard doesn't need to be sophisticated at first. It needs to let the team trace the path from first contact to cash.
- total investment and direct media spend
- identified contacts by source
- scheduled and completed new patient exams
- new patients, according to your documented definition
- median time between first contact and first payment
- media CAC and full patient acquisition cost
- contribution observed at 90 days and at 12 months
- recall visits recommended, overdue and completed, when clinically appropriate
- balancing measures such as wait times, no-shows, cancellations, complaints and overtime
Google Ads calculates cost per conversion by dividing total cost by the number of conversions you've set up. That's a reminder to be careful: if the platform's conversion is "form submitted," it shouldn't be compared directly with a CAC based on first payment.
Ethics and privacy belong in the math
Dental advertising has rules. Before using patient photos, testimonials or offers to attract new patients, check the advertising and ethics requirements that apply to dentists in your state. Avoid sensationalism and promises of results.
Health information is sensitive, and in the U.S. it's often protected under HIPAA. In practice, marketing measurement should use only the data it needs, control who has access and keep diagnoses, clinical records and treatment details out of ad platforms. Consent, data sharing and tracking tools should be reviewed with legal and privacy guidance.
Management limit: a channel isn't economically sound if it depends on non-compliant advertising, excessive use of data, promised results or pressure on clinical recommendations.
How HartSystem fits into this decision
ProDent brings together an integrated CRM, referral tracking and campaigns, lead source reports, scheduling, treatment plans, billing, management indicators and the Pro365 AI Consultant.
Together, these features help the clinic connect evidence that usually lives in separate places: where the contact came from, the stage of the opportunity, attendance, the treatment plan, payment and the ongoing relationship. The Pro365 AI Consultant can help answer questions about the data you already have, while personalized consulting can help turn that insight into a process rule, an owner and a review date.
Growth means buying the right demand, not more leads
This week, pick one channel and one recent cohort. Rebuild five data points: full cost, source, first visit, first payment and observed contribution. Then check whether the clinic had the capacity to absorb that demand without making wait times, no-shows, rework or the patient experience worse.
Growing isn't about buying more contacts. It's about attracting the right demand at a compatible cost, converting it ethically, getting paid on time, protecting capacity and sustaining a care relationship that makes sense for the patient.
With Pro365 GO, the new ProDent that runs 100% on the web, lead source, treatment plans, payments and KPIs live in one place, so your CAC rests on real data. Book a demo to see it with your own numbers.
